Adenosine inhibits the release of interleukin-1beta in activated human peripheral mononuclear cells |
| |
Authors: | Sipka Sandor Kovács Ildikó Szántó Sándor Szegedi Gyula Brugós László Bruckner Geza József Szentmiklósi A |
| |
Affiliation: | 3rd Department of Internal Medicine, University of Debrecen, Hungary. sipka@iiibel.dote.hu |
| |
Abstract: | The effects of adenosine and subtype-specific activators of adenosine receptors (A1, A2A, A2B and A3) were studied on the release of interleukin-1beta (IL-1beta) from peripheral mononuclear cells, monocytes and lymphocytes. In the cells activated by the protein kinase C specific phorbol ester (phorbol 12-myristate 13-acetate) and Ca(2+) ionophore (A23187) both adenosine and the subtype-specific receptor agonists, CPA (A1), CGS 21680 (A2A) and IB-MECA (A3) induced a concentration-dependent inhibition of IL-1beta release. The rank order of potency in the inhibition of IL-1beta release was CPA=CGS 21680>IB-MECA>adenosine>NECA (in the presence of A1, A2A and A3 receptor inhibitors). The inhibitory actions of CPA, CGS 21680 or IB-MECA were significantly reduced in the presence of DPCPX, ZM 243185 or MRS 1191 as subtype-specific antagonists on A1, A2A and A3 adenosine receptors, respectively. It can be concluded that adenosine inhibits the release of IL-1beta from the activated human peripheral mononuclear cells. In this process A1, A2A and A3 receptors are involved. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|